Evidence map›Paper›PMID 29427666›Full record

ArticleBiochemical and biophysical research communications2018

Quantitative monitoring of two simultaneously binding species using Label-Enhanced surface plasmon resonance.

Lars Eng, Brandon L Garcia, Brian V Geisbrecht, Anders Hanning

Abstract readEvaluation Study
In one paragraph

Article in Biochemical and biophysical research communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lars EngEpisentum, Karins väg 5, 194 61 Upplands Väsby, Sweden.
Brandon L GarciaDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66506, USA.
Brian V GeisbrechtDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66506, USA.
Anders HanningEpisentum, Karins väg 5, 194 61 Upplands Väsby, Sweden. Electronic address: anders.hanning@episentum.com.

Funding

Novel Staphylococcal Inhibitors of Neutrophil Granule EnzymesR01GM121511 · NIGMS · KANSAS STATE UNIVERSITY · PI GEISBRECHT, BRIAN V · 2017 to 2020
$1.2M
Cheminformatic Discovery of Alternative Pathway C3 Pro-Convertase InhibitorsR21AI113552 · NIAID · KANSAS STATE UNIVERSITY · PI GEISBRECHT, BRIAN V · 2014 to 2015
$439k
Classical Complement Pathway Evasion Mechanisms of Lyme Disease SpirochetesR21AI133367 · NIAID · KANSAS STATE UNIVERSITY · PI GARCIA, BRANDON LEE, SKARE, JON T · 2017 to 2018
$435k
Development of Small Molecule Inhibitors of the Classical Complement PathwayR21NS102766 · NINDS · KANSAS STATE UNIVERSITY · PI GARCIA, BRANDON LEE · 2017 to 2018
$413k
Inhibition of the Classical & Lectin Complement Pathways by Staphylococcus aureus EapR21AI111203 · NIAID · KANSAS STATE UNIVERSITY · PI GEISBRECHT, BRIAN V · 2015 to 2016
$375k
NIAID NIH HHS R21 AI111203NIAID NIH HHS R21 AI113552NIAID NIH HHS R21 AI133367NIGMS NIH HHS R01 GM121511NINDS NIH HHS R21 NS102766
6 · The paper itself

Abstract

Surface plasmon resonance (SPR) is a well-established method for biomolecular interaction studies. SPR monitors the binding of molecules to a solid surface, embodied as refractive index changes close to the surface. One limitation of conventional SPR is the universal nature of the detection that results in an inability to qualitatively discriminate between different binding species. Furthermore, it is impossible to directly discriminate two species simultaneously binding to different sites on a protein, which limits the utility of SPR, for example, in the study of allosteric binders or bi-specific molecules. It is also impossible in principle to discriminate protein conformation changes from actual binding events. Here we demonstrate how Label-Enhanced SPR can be utilized to discriminate and quantitatively monitor the simultaneous binding of two different species - one dye-labeled and one unlabeled - on a standard, single-wavelength SPR instrument. This new technique increases the versatility of SPR technology by opening up application areas where the usefulness of the approach has previously been limited.

Indexed as

Binding SitesColoring AgentsKineticsMolecular ImagingProtein BindingProtein Interaction MappingProteinsReproducibility of ResultsSensitivity and SpecificityStaining and LabelingSurface Plasmon ResonanceColoring AgentsProteinsDye labelingEktogramEpigramLabel-Enhanced SPRSPRSurface plasmon resonance

Identifiers

PMID29427666
PMCPMC5835214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.